EcoDrugPlus

Ensembl ID : ENSTNIG00000008315
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSTNIG00000011262
Gene Symbol: -
2 Cross references
187 Possible Orthologues:

Ensembl ID : ENSTNIG00000011613
Gene Symbol: -
1 Cross references
179 Possible Orthologues:

Ensembl ID : ENSTNIG00000012130
Gene Symbol: -
1 Cross references
185 Possible Orthologues:

Ensembl ID : ENSTNIG00000012820
Gene Symbol: -
1 Cross references
203 Possible Orthologues:

Ensembl ID : ENSTNIG00000014128
Gene Symbol: -
1 Cross references
157 Possible Orthologues:

Ensembl ID : ENSTNIG00000018344
Gene Symbol: -
1 Cross references
354 Possible Orthologues:

Ensembl ID : ENSTNIG00000018823
Gene Symbol: -
1 Cross references
183 Possible Orthologues:

Ensembl ID : ENSTNIG00000019549
Gene Symbol: -
1 Cross references
405 Possible Orthologues:

Ensembl ID : ENSTNIG00000019522
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSTNIG00000001963
Gene Symbol: -
1 Cross references
11 Possible Orthologues:

Ensembl ID : ENSTNIG00000001849
Gene Symbol: -
1 Cross references
48 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).